Stuart Varney and David Bahnsen analyze the ongoing tech sell-off, noting Apple’s rise as the most valuable company. Bahnsen shares Merck & Co. (MRK) as a dividend pick, citing its FDA approval for an oral cholesterol drug.
David Bahnsen joins Stuart Varney to discuss the tech sell-off impacting Nasdaq and the S&P 500, with Apple replacing Nvidia as the world’s most valuable company at $4.5 trillion. Bahnsen recommends Merck & Co. (MRK) as a dividend growth stock due to recent FDA approval for its new oral cholesterol drug, highlighting its diversification strategy.
Read the full article here